These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23046584)

  • 1. Renal progenitors in non-diabetic and diabetic nephropathies.
    Romagnani P; Remuzzi G
    Trends Endocrinol Metab; 2013 Jan; 24(1):13-20. PubMed ID: 23046584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury.
    Angelotti ML; Ronconi E; Ballerini L; Peired A; Mazzinghi B; Sagrinati C; Parente E; Gacci M; Carini M; Rotondi M; Fogo AB; Lazzeri E; Lasagni L; Romagnani P
    Stem Cells; 2012 Aug; 30(8):1714-25. PubMed ID: 22628275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney regeneration: any prospects?
    Romagnani P
    Contrib Nephrol; 2011; 170():228-236. PubMed ID: 21659775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regeneration and the kidney.
    Lazzeri E; Mazzinghi B; Romagnani P
    Curr Opin Nephrol Hypertens; 2010 May; 19(3):248-53. PubMed ID: 20061947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gas1 expression in parietal cells of Bowman's capsule in experimental diabetic nephropathy.
    Luna-Antonio BI; Rodriguez-Muñoz R; Namorado-Tonix C; Vergara P; Segovia J; Reyes JL
    Histochem Cell Biol; 2017 Jul; 148(1):33-47. PubMed ID: 28315934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoids and the renal proximal tubule: an emerging role in diabetic nephropathy.
    Jenkin KA; Verty AN; McAinch AJ; Hryciw DH
    Int J Biochem Cell Biol; 2012 Nov; 44(11):2028-31. PubMed ID: 22842535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetogenic transferrin damages podocytes in early human diabetic nephropathy.
    Gonzalez S; Vargas L
    Horm Metab Res; 2001 Feb; 33(2):84-8. PubMed ID: 11294498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy.
    Zoja C; Garcia PB; Rota C; Conti S; Gagliardini E; Corna D; Zanchi C; Bigini P; Benigni A; Remuzzi G; Morigi M
    Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1370-81. PubMed ID: 22952284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Growth factors and renal regeneration].
    Flaquer M; Romagnani P; Cruzado JM
    Nefrologia; 2010; 30(4):385-93. PubMed ID: 20651879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy.
    Sanchez-Niño MD; Bozic M; Córdoba-Lanús E; Valcheva P; Gracia O; Ibarz M; Fernandez E; Navarro-Gonzalez JF; Ortiz A; Valdivielso JM
    Am J Physiol Renal Physiol; 2012 Mar; 302(6):F647-57. PubMed ID: 22169009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redistribution of connexin43 expression in glomerular podocytes predicts poor renal prognosis in patients with type 2 diabetes and overt nephropathy.
    Sawai K; Mukoyama M; Mori K; Yokoi H; Koshikawa M; Yoshioka T; Takeda R; Sugawara A; Kuwahara T; Saleem MA; Ogawa O; Nakao K
    Nephrol Dial Transplant; 2006 Sep; 21(9):2472-7. PubMed ID: 16820374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cells and kidney injury.
    Vigneau C; Zheng F; Polgar K; Wilson PD; Striker G
    Curr Opin Nephrol Hypertens; 2006 May; 15(3):238-44. PubMed ID: 16609289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocyte hypertrophy in diabetic nephropathy.
    Kim NH
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging role of angiotensin-converting enzyme-2 in the kidney.
    Burns KD
    Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):116-21. PubMed ID: 17293686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward the identification of a "renopoietic system"?
    Romagnani P
    Stem Cells; 2009 Sep; 27(9):2247-53. PubMed ID: 19739254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kidney regeneration update].
    Hishikawa K; Fujita T
    Nihon Rinsho; 2008 May; 66(5):941-7. PubMed ID: 18464514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the potassium channel KCa3.1 in diabetic nephropathy.
    Huang C; Pollock CA; Chen XM
    Clin Sci (Lond); 2014 Oct; 127(7):423-33. PubMed ID: 24963668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired Regeneration Potential in Urinary Stem Cells Diagnosed from the Patients with Diabetic Nephropathy.
    Xiong G; Tang W; Zhang D; He D; Wei G; Atala A; Liang XJ; Bleyer AJ; Bleyer ME; Yu J; Aloi JA; Ma JX; Furdui CM; Zhang Y
    Theranostics; 2019; 9(14):4221-4232. PubMed ID: 31281543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of basic fibroblast growth factor (FGF-2) in diabetic nephropathy and mechanisms of its induction by hyperglycemia in human renal fibroblasts.
    Vasko R; Koziolek M; Ikehata M; Rastaldi MP; Jung K; Schmid H; Kretzler M; Müller GA; Strutz F
    Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1452-63. PubMed ID: 19279131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes.
    Zhang D; Yang H; Kong X; Wang K; Mao X; Yan X; Wang Y; Liu S; Zhang X; Li J; Chen L; Wu J; Wei M; Yang J; Guan Y
    Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E287-95. PubMed ID: 20959534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.